The Gross Margin of Oncopeptides AB (ONCO.ST) is 91.59%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 91.59% |
| 2023-12-31 | 103.06% |
| 2022-12-31 | 99.93% |
| 2021-12-31 | 55.09% |